Kooth vs Pfizer

Side-by-side comparison of AI visibility scores, market position, and capabilities

Pfizer leads in AI visibility (93 vs 52)
Kooth logo

Kooth

ChallengerHealthcare

Digital Mental Health & Wellbeing Platform for Young People

Kooth is a publicly traded UK digital mental health company (AIM: KOO) providing NHS-commissioned mental health services for under-18s; 2025 revenues of £63.3M; serves 20M+ people in the US and UK; operates in 3 U.S.

AI VisibilityBeta
Overall Score
C52
Category Rank
#279 of 596
AI Consensus
90%
Trend
stable
Per Platform
ChatGPT
57
Perplexity
58
Gemini
55

About

Kooth Digital Health is a UK-based digital mental health and wellbeing company founded in 2001, incorporated as a private limited company and publicly listed on the London Stock Exchange AIM market under the ticker KOO. Kooth is the largest single-access provider of digital mental health services for children and young people under 18 in NHS England, providing free, accessible, clinically robust support with no waiting lists. The platform gives young people aged 11 to 25 access to an online community of peers, structured self-help content, and a team of experienced counsellors — available through web and mobile, with no referral required.

Full profile
Pfizer logo

Pfizer

LeaderHealthcare Tech

Enterprise

Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.

AI VisibilityBeta
Overall Score
A93
Category Rank
#1 of 596
AI Consensus
80%
Trend
stable
Per Platform
ChatGPT
94
Perplexity
89
Gemini
94

About

Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.

Full profile

AI Visibility Head-to-Head

52
Overall Score
93
#279
Category Rank
#1
90
AI Consensus
80
stable
Trend
stable
57
ChatGPT
94
58
Perplexity
89
55
Gemini
94
55
Claude
92
54
Grok
98

Key Details

Category
Digital Mental Health & Wellbeing Platform for Young People
Enterprise
Tier
Challenger
Leader
Entity Type
brand
company

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.